ARTICLE | Company News
V. I. Technologies Inc. blood products/substitutes news
March 12, 2001 8:00 AM UTC
VITX signed a letter of intent for a management-led divestment of its plasma program that produces virally inactivated plasma for transfusion including VITX's PLAS+SD and intermediate plasma fraction...